Yüklüyor......
Binding of the small-molecule kinase inhibitor ruxolitinib to membranes does not disturb membrane integrity
Ruxolitinib is a small-molecule protein kinase inhibitor, which is used as a therapeutic agent against several diseases. Due to its anti-inflammatory impact, ruxolitinib has also been considered recently for usage in the treatment of Covid-19. While the specific effects of ruxolitinib on Janus kinas...
Kaydedildi:
| Yayımlandı: | Biochem Biophys Rep |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7642770/ https://ncbi.nlm.nih.gov/pubmed/33195828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrep.2020.100838 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|